상세 보기
Diagnostic and Prognostic Impact of Osteopontin Expression in Endometrial Cancer
- Cho, HanByoul;
- Kang, Eun Suk;
- Kim, Young Tae;
- Kim, Jae-Hoon
WEB OF SCIENCE
18SCOPUS
18초록
The role of osteopontin as a biomarker in endometrial cancer has not been conclusively established. We evaluated the expression and potential of osteopontin as a biomarker for endometrial cancer. Real-time polymerase chain reaction and immunohistochemistry revealed osteopontin overexpression in endometrial cancer. The plasma osteopontin level in endometrial cancer was significantly higher than in healthy controls (P < 0.001). In FIGO stage I endometrial cancer, osteopontin correctly identified 18 of 29 cases (62.1%) that were not detected by CA125. By Cox multivariate analysis, osteopontin positivity was an independent prognostic factor for disease-free survival (hazard ratio = 3.18, P = 0.035).
키워드
- 제목
- Diagnostic and Prognostic Impact of Osteopontin Expression in Endometrial Cancer
- 저자
- Cho, HanByoul; Kang, Eun Suk; Kim, Young Tae; Kim, Jae-Hoon
- 발행일
- 2009-01
- 유형
- Article
- 권
- 27
- 호
- 3
- 페이지
- 313 ~ 323
- 언어
- ENG
- 출판사
- Marcel Dekker Inc.
- 발행국가
- 미국
- 분량
- 11 페이지
- ISSN
- E 1532-4192
P 0735-7907